Communiqués Alvotech

Actions

ALVO

LU2458332611

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX Autres places de cotation 17:47:06 16/07/2026			Varia. 5j.	Varia. 1 janv.
3,365 ^USD	-0,44%		-0,59%	-34,11%

06/07	Alvotech : un deuxième trimestre en demi-teinte mais un fort potentiel sur le marché des biosimilaires, selon UBS	MT
01/07	Les ETF et les contrats à terme sur indices en baisse mercredi avant la première intervention internationale du président de la Fed, Kevin Warsh	MT

Communiqués

03/07	Transactions of Managers and Closely Associated Persons	GL
02/07	Janssen Files BPCIA Complaint Against Alvotech Related To Golimumab Biosimilar	AQ
01/07	Alvotech further strengthens liquidity by securing term loan facility of $75 million	GL
23/06	Transactions of Managers and Closely Associated Persons	GL
18/06	Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA	AQ
18/06	Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement	GL
16/06	Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement	GL
15/06	Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares	GL
10/06	Transactions of Managers and Closely Associated Persons	GL
08/06	Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®	GL
04/06	Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®	GL
03/06	Main Results of 2026 Annual and Extraordinary General Meeting	GL
02/06	Alvotech to present at upcoming investor conferences in June	GL
01/06	Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland	GL
11/05	Alvotech announces completion of FDA surveillance inspection at Reykjavik facility	GL
07/05	Alvotech : Q1 2026 - Press Release	PU
07/05	Alvotech : Q1 2026 - Earnings Report	PU
07/05	Alvotech : Q1 2026 - Presentation	PU
06/05	Alvotech Q1 2026 Financial Results	GL
30/04	Alvotech Announces a Change in its Executive Team	GL
30/04	Alvotech : General Meeting - ALVOTECH	PU
27/04	Alvotech to Report Financial Results for the First Quarter of 2026	AQ
24/04	Alvotech to Report Financial Results for the First Quarter of 2026	GL
23/04	Alvotech : Inside Information / Ad Hoc Information - ALVOTECH	PU
23/04	Alvotech : Inside Information / Ad Hoc Information - Consolidated Annual Financial Statements - EN	PU